Virtus ETF Advisers’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-43,789
| Closed | -$356K | – | 557 |
|
|
2024
Q4 | $356K | Buy |
43,789
+13,711
| +46% | +$111K | 0.15% | 196 |
|
|
2024
Q3 | $544K | Hold |
30,078
| – | – | 0.25% | 181 |
|
|
2024
Q2 | $310K | Buy |
30,078
+20,377
| +210% | +$210K | 0.15% | 224 |
|
|
2024
Q1 | $103K | Sell |
9,701
-666
| -6% | -$7.07K | 0.05% | 359 |
|
|
2023
Q4 | $94.7K | Buy |
10,367
+2,623
| +34% | +$23.9K | 0.06% | 386 |
|
|
2023
Q3 | $80.3K | Sell |
7,744
-771
| -9% | -$8K | 0.05% | 360 |
|
|
2023
Q2 | $122K | Buy |
+8,515
| New | +$122K | 0.07% | 328 |
|
|
2022
Q4 | – | Sell |
-16,847
| Closed | -$187K | – | 476 |
|
|
2022
Q3 | $187K | Buy |
16,847
+121
| +0.7% | +$1.34K | 0.07% | 326 |
|
|
2022
Q2 | $141K | Buy |
16,726
+8,151
| +95% | +$68.7K | 0.05% | 329 |
|
|
2022
Q1 | $117K | Sell |
8,575
-505
| -6% | -$6.89K | 0.05% | 273 |
|
|
2021
Q4 | $179K | Buy |
9,080
+2,930
| +48% | +$57.8K | 0.07% | 250 |
|
|
2021
Q3 | $197K | Sell |
6,150
-326
| -5% | -$10.4K | 0.09% | 272 |
|
|
2021
Q2 | $219K | Sell |
6,476
-277
| -4% | -$9.37K | 0.09% | 279 |
|
|
2021
Q1 | $254K | Buy |
6,753
+118
| +2% | +$4.44K | 0.11% | 285 |
|
|
2020
Q4 | $220K | Buy |
6,635
+393
| +6% | +$13K | 0.09% | 336 |
|
|
2020
Q3 | $229K | Sell |
6,242
-834
| -12% | -$30.6K | 0.12% | 282 |
|
|
2020
Q2 | $233K | Buy |
+7,076
| New | +$233K | 0.11% | 324 |
|